Porton Pharma Solutions (SZSE:300363) Days Sales Outstanding : 89.91 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Days Sales Outstanding?

Porton Pharma Solutions's average Accounts Receivable for the three months ended in Mar. 2024 was ¥668 Mil. Porton Pharma Solutions's Revenue for the three months ended in Mar. 2024 was ¥678 Mil. Hence, Porton Pharma Solutions's Days Sales Outstanding for the three months ended in Mar. 2024 was 89.91.

The historical rank and industry rank for Porton Pharma Solutions's Days Sales Outstanding or its related term are showing as below:

SZSE:300363' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.64 Med: 78.66 Max: 107.35
Current: 107.35

During the past 13 years, Porton Pharma Solutions's highest Days Sales Outstanding was 107.35. The lowest was 64.64. And the median was 78.66.

SZSE:300363's Days Sales Outstanding is ranked worse than
77.96% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.69 vs SZSE:300363: 107.35

Porton Pharma Solutions's Days Sales Outstanding declined from Mar. 2023 (93.33) to Mar. 2024 (89.91).

Porton Pharma Solutions Days Sales Outstanding Historical Data

The historical data trend for Porton Pharma Solutions's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Days Sales Outstanding Chart

Porton Pharma Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

70.81

66.09

84.40

64.64

106.15

Porton Pharma Solutions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															93.33	110.30	108.86	99.96	89.91

Competitive Comparison of Porton Pharma Solutions's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Porton Pharma Solutions's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's Days Sales Outstanding falls into.

Porton Pharma Solutions Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Porton Pharma Solutions's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1456.609	+	676.427)	/	2 )	/	3667.417	*	365
=	1066.518					/	3667.417	*	365
=	106.15

Porton Pharma Solutions's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (676.427	+	659.13)	/	2 )	/	677.718	*	365 / 4
=	667.7785					/	677.718	*	365 / 4
=	89.91

Porton Pharma Solutions (SZSE:300363) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Porton Pharma Solutions Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Porton Pharma Solutions (SZSE:300363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714

Website

http://www.porton.cn

Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.

Executives

Wang Zhong Neng	Executives
Yu Yong Mei	Executives
Sun Min	Executives
Ji Yao Hui	Executives
Ju Nian Feng	Directors, executives
Tan Jun	Supervisors
Xu Ai Wu	Directors, executives
Guo Yong Qing	Independent director
	Director
	Director
Ceng Hui	Supervisors
Chen Bei	Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines